PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 19 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanol extracts of root and rhizome (200 and 400 mg/kg) significantly reduced elevated serum levels of ALT, AST, ALP, and total bilirubin, while increasing total protein and albumin in Wistar rats [PMID:23152428].
Methanolic extracts of stems demonstrated antioxidant potential and the ability to scavenge reactive oxygen species in vitro [PMID:25901714].
Evidence summary
PubMed sources
- 1.PMID: 40282410 (2025) — Assembly and Comparative Analysis of the Complete Mitochondrial Genomes of Smilax glabra and Smilax zeylanica. · Genes
- 2.PMID: 38353477 (2025) — Benzoic acid, 4-hydroxy-, methyl ester from Smilax zeylanica Linn emerges as a potent inhibitor of CD27/CD70 signaling pathway. · Journal of biomolecular structure & dynamics
- 3.PMID: 23152428 (2012) — Effect of Smilax zeylanica roots and rhizomes in paracetamol induced hepatotoxicity. · Journal of complementary & integrative medicine
- 4.PMID: 25901714 (2015) — Antioxidant and cytotoxic activity of stems of Smilax zeylanica in vitro. · Journal of basic and clinical physiology and pharmacology